IL6 and chronic obstructive pulmonary disease: Because chronic inflammation (“inflamm-ageing”) is associated with both frailty and immune dysfunction, we investigated whether there were any relationships with circulating inflammatory mediators, specifically tumour necrosis factor, interleukin (IL)-1β and IL-6 and chronic health conditions such as cardiovascular disease, dementia and COPD.